Market Closed -
Hong Kong S.E.
04:08:11 2024-05-08 am EDT
|
5-day change
|
1st Jan Change
|
0.275
HKD
|
0.00%
|
|
-1.79%
|
-15.38%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
5,193
|
5,193
|
5,193
|
3,311
|
2,584
|
2,201
|
Enterprise Value (EV)
1 |
3,443
|
3,453
|
3,512
|
1,533
|
1,820
|
1,421
|
P/E ratio
|
81.2
x
|
-618
x
|
-18.5
x
|
150
x
|
183
x
|
-11.3
x
|
Yield
|
0.36%
|
-
|
-
|
0.34%
|
0.32%
|
0.37%
|
Capitalization / Revenue
|
4.63
x
|
4.6
x
|
4.86
x
|
2.23
x
|
1.68
x
|
1.2
x
|
EV / Revenue
|
3.07
x
|
3.06
x
|
3.28
x
|
1.03
x
|
1.19
x
|
0.78
x
|
EV / EBITDA
|
53.3
x
|
42.5
x
|
408
x
|
9.15
x
|
23
x
|
8.08
x
|
EV / FCF
|
64.7
x
|
-16.6
x
|
14.4
x
|
6.76
x
|
-15.9
x
|
8.42
x
|
FCF Yield
|
1.55%
|
-6.02%
|
6.95%
|
14.8%
|
-6.29%
|
11.9%
|
Price to Book
|
1.28
x
|
1.29
x
|
1.36
x
|
0.86
x
|
0.74
x
|
0.68
x
|
Nbr of stocks (in thousands)
|
7,526,134
|
7,526,134
|
7,526,134
|
7,526,134
|
6,800,548
|
6,773,522
|
Reference price
2 |
0.6900
|
0.6900
|
0.6900
|
0.4400
|
0.3800
|
0.3250
|
Announcement Date
|
4/17/19
|
4/8/20
|
4/23/21
|
4/27/22
|
4/27/23
|
4/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,122
|
1,129
|
1,069
|
1,484
|
1,536
|
1,833
|
EBITDA
1 |
64.64
|
81.24
|
8.604
|
167.5
|
79.26
|
175.8
|
EBIT
1 |
7.3
|
24.29
|
-48.71
|
114.1
|
16.49
|
105.7
|
Operating Margin
|
0.65%
|
2.15%
|
-4.56%
|
7.69%
|
1.07%
|
5.77%
|
Earnings before Tax (EBT)
1 |
115
|
38.77
|
-232.9
|
126.5
|
82.5
|
-120.9
|
Net income
1 |
64.01
|
-8.414
|
-281
|
22.01
|
15.29
|
-194.2
|
Net margin
|
5.71%
|
-0.75%
|
-26.29%
|
1.48%
|
1%
|
-10.59%
|
EPS
2 |
0.008500
|
-0.001117
|
-0.0373
|
0.002924
|
0.002082
|
-0.0287
|
Free Cash Flow
1 |
53.25
|
-208.1
|
244.1
|
226.9
|
-114.4
|
168.9
|
FCF margin
|
4.75%
|
-18.43%
|
22.83%
|
15.29%
|
-7.45%
|
9.21%
|
FCF Conversion (EBITDA)
|
82.38%
|
-
|
2,836.78%
|
135.46%
|
-
|
96.05%
|
FCF Conversion (Net income)
|
83.18%
|
-
|
-
|
1,030.62%
|
-
|
-
|
Dividend per Share
2 |
0.002500
|
-
|
-
|
0.001500
|
0.001200
|
0.001200
|
Announcement Date
|
4/17/19
|
4/8/20
|
4/23/21
|
4/27/22
|
4/27/23
|
4/29/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
1,750
|
1,740
|
1,682
|
1,779
|
764
|
780
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
53.2
|
-208
|
244
|
227
|
-114
|
169
|
ROE (net income / shareholders' equity)
|
1.98%
|
0.24%
|
-6.13%
|
1.8%
|
1.23%
|
-4.26%
|
ROA (Net income/ Total Assets)
|
0.1%
|
0.32%
|
-0.65%
|
1.53%
|
0.22%
|
1.43%
|
Assets
1 |
65,320
|
-2,597
|
43,025
|
1,437
|
7,036
|
-13,592
|
Book Value Per Share
2 |
0.5400
|
0.5300
|
0.5100
|
0.5100
|
0.5100
|
0.4800
|
Cash Flow per Share
2 |
0.2300
|
0.2400
|
0.1400
|
0.1200
|
0.1400
|
0.1500
|
Capex
1 |
79.7
|
55
|
35.3
|
19.9
|
37.2
|
17.7
|
Capex / Sales
|
7.1%
|
4.87%
|
3.3%
|
1.34%
|
2.42%
|
0.97%
|
Announcement Date
|
4/17/19
|
4/8/20
|
4/23/21
|
4/27/22
|
4/27/23
|
4/29/24
|
|
1st Jan change
|
Capi.
|
---|
| -15.38% | 238M | | +16.17% | 82.36B | | -29.41% | 69.97B | | +10.99% | 29.41B | | -11.35% | 16.99B | | +0.39% | 17.08B | | -0.68% | 15.21B | | +1.48% | 11.84B | | +3.44% | 13.25B | | +31.43% | 12.08B |
Other Healthcare Facilities & Services
|